TW200730510A - Chroman compounds - Google Patents
Chroman compoundsInfo
- Publication number
- TW200730510A TW200730510A TW095140588A TW95140588A TW200730510A TW 200730510 A TW200730510 A TW 200730510A TW 095140588 A TW095140588 A TW 095140588A TW 95140588 A TW95140588 A TW 95140588A TW 200730510 A TW200730510 A TW 200730510A
- Authority
- TW
- Taiwan
- Prior art keywords
- chroman compounds
- methods
- compounds
- chroman
- pharmaceutically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73399305P | 2005-11-04 | 2005-11-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200730510A true TW200730510A (en) | 2007-08-16 |
Family
ID=38006136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095140588A TW200730510A (en) | 2005-11-04 | 2006-11-02 | Chroman compounds |
Country Status (8)
Country | Link |
---|---|
US (2) | US20070185107A1 (zh) |
EP (1) | EP1945624A4 (zh) |
JP (1) | JP2009514854A (zh) |
CN (1) | CN101356167A (zh) |
AR (1) | AR056175A1 (zh) |
TW (1) | TW200730510A (zh) |
UY (1) | UY29892A1 (zh) |
WO (1) | WO2007053095A1 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9703377D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
UY29892A1 (es) * | 2005-11-04 | 2007-06-29 | Astrazeneca Ab | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones |
US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
TW200920369A (en) | 2007-10-26 | 2009-05-16 | Amira Pharmaceuticals Inc | 5-lipoxygenase activating protein (flap) inhibitor |
WO2009116071A2 (en) * | 2008-02-05 | 2009-09-24 | Watson Pharma Private Limited | An improved process for preparation of paliperidone |
SG190667A1 (en) | 2008-05-23 | 2013-06-28 | Panmira Pharmaceuticals Llc | 5-lipoxygenase-activating protein inhibitor |
US8546431B2 (en) | 2008-10-01 | 2013-10-01 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5112856A (en) * | 1986-08-15 | 1992-05-12 | Hoffmann-La Roche Inc. | Therapeutic treatment of intestinal inflammation by administration of 3,4-dihydro-2H-1-benzopyran derivatives |
US4912096A (en) * | 1989-06-26 | 1990-03-27 | E. R. Squibb & Sons, Inc. | Method for preventing or treating depression employing an ace inhibitor |
US5605896A (en) * | 1992-02-25 | 1997-02-25 | Recordati S.A., Chemical And Pharmaceutical Company | Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities |
FR2760014B1 (fr) * | 1997-02-27 | 1999-04-09 | Adir | Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2761358B1 (fr) * | 1997-03-27 | 1999-05-07 | Adir | Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6034256A (en) * | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
FR2782515B1 (fr) * | 1998-08-21 | 2000-09-22 | Adir | NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
EP1353914A2 (en) * | 2001-01-16 | 2003-10-22 | AstraZeneca AB | Therapeutic chromone compounds |
BR0206512A (pt) * | 2001-01-16 | 2004-01-06 | Astrazeneca Ab | Composto, método de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de um composto, e, processo para preparar um composto. |
CN100384833C (zh) * | 2001-01-16 | 2008-04-30 | 阿斯特拉曾尼卡有限公司 | 治疗用苯并二氢吡喃化合物 |
US7052486B2 (en) * | 2003-01-02 | 2006-05-30 | Medtronic, Inc. | Method and system for treating depressive and anxiety disorders |
UY29892A1 (es) * | 2005-11-04 | 2007-06-29 | Astrazeneca Ab | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones |
WO2007053093A1 (en) * | 2005-11-04 | 2007-05-10 | Astrazeneca Ab | Chroman compounds as 5 ht1b antagonists |
UY29896A1 (es) * | 2005-11-04 | 2007-06-29 | Astrazeneca Ab | Nuevos derivados de cromano, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones |
-
2006
- 2006-11-01 UY UY29892A patent/UY29892A1/es not_active Application Discontinuation
- 2006-11-02 TW TW095140588A patent/TW200730510A/zh unknown
- 2006-11-03 JP JP2008538846A patent/JP2009514854A/ja active Pending
- 2006-11-03 WO PCT/SE2006/001254 patent/WO2007053095A1/en active Application Filing
- 2006-11-03 AR ARP060104835A patent/AR056175A1/es unknown
- 2006-11-03 US US11/592,686 patent/US20070185107A1/en not_active Abandoned
- 2006-11-03 CN CNA2006800504401A patent/CN101356167A/zh active Pending
- 2006-11-03 EP EP06812977A patent/EP1945624A4/en not_active Withdrawn
-
2009
- 2009-03-13 US US12/403,553 patent/US20090170851A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
UY29892A1 (es) | 2007-06-29 |
US20070185107A1 (en) | 2007-08-09 |
US20090170851A1 (en) | 2009-07-02 |
AR056175A1 (es) | 2007-09-19 |
WO2007053095A1 (en) | 2007-05-10 |
EP1945624A1 (en) | 2008-07-23 |
JP2009514854A (ja) | 2009-04-09 |
EP1945624A4 (en) | 2010-06-30 |
CN101356167A (zh) | 2009-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200730511A (en) | Chroman compounds | |
TW200730510A (en) | Chroman compounds | |
ES2368594T3 (es) | Derivados sustituidos de ciclohexilmetilo. | |
MX2009011205A (es) | Derivados de 2-iminoisotiazol como ligandos del receptor canabinoide. | |
MXPA06000921A (es) | Derivados de benzamidazoles como inhibidores de mek. | |
NO20071593L (no) | Pyrimidinderivater | |
TW200745067A (en) | Novel compounds | |
TW200732323A (en) | Organic compounds | |
MX2010003366A (es) | Derivados de piperidina y piperazina para el tratamiento de tumores. | |
TN2011000279A1 (en) | Novel pyrazole -4-n-alkoxycarboxamides as microbiocides | |
DK1881967T3 (da) | Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika | |
TW200716584A (en) | Dihydrobenzofuran derivatives and uses thereof | |
WO2007061360A3 (en) | Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides | |
MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
DE602005014473D1 (en) | Amino-propanolderivate | |
JO2734B1 (en) | Organic compounds | |
JO2770B1 (en) | Organic compounds | |
MX2010009022A (es) | Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso. | |
PL1877367T3 (pl) | Pochodne acetylenu | |
JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
MX2009012374A (es) | Compuestos novedosos como ligandos del receptor de canabinoides. | |
TW200714598A (en) | Urea derivatives, methods for their manufacture, and uses therefor | |
UA96759C2 (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
JO2749B1 (en) | Indole-2-Wen derivatives bilaterally substituted at position 3, their preparation and therapeutic application | |
ZA200801875B (en) | Isoquinolines as IGF-IR inhibitors |